These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Evaluation of the postnatal treatment efficacy in congenital toxoplasmosis identified by the newborn screening programme]. Paul M, Jaworska A, Twardosz-Pawlik H, Szczapa J, Stefaniak J. Wiad Parazytol; 2001 Feb; 47 Suppl 1():107-12. PubMed ID: 16897960 [Abstract] [Full Text] [Related]
8. Diagnostic problems and postnatal follow-up in congenital toxoplasmosis. Mazzola A, Casuccio A, Romano A, Schimmenti MG, Titone L, Di Carlo P. Minerva Pediatr; 2007 Jun; 59(3):207-13. PubMed ID: 17519865 [Abstract] [Full Text] [Related]
9. Congenital toxoplasmosis. Jones J, Lopez A, Wilson M. Am Fam Physician; 2003 May 15; 67(10):2131-8. PubMed ID: 12776962 [Abstract] [Full Text] [Related]
13. Increasing toxoplasma seropositivity in women with bad obstetric history and in newborns. Sharma P, Gupta I, Ganguly NK, Mahajan RC, Malla N. Natl Med J India; 1997 May 15; 10(2):65-6. PubMed ID: 9153982 [Abstract] [Full Text] [Related]
14. Treatment of toxoplasmosis in the pregnant mother and newborn child. Stray-Pedersen B. Scand J Infect Dis Suppl; 1992 May 15; 84():23-31. PubMed ID: 1290070 [Abstract] [Full Text] [Related]
19. Active control of congenital toxoplasmosis in the population. Palicka P, Slabá H, Zitek K. Cent Eur J Public Health; 1998 Nov 15; 6(4):265-8. PubMed ID: 9919374 [Abstract] [Full Text] [Related]
20. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Foulon W, Villena I, Stray-Pedersen B, Decoster A, Lappalainen M, Pinon JM, Jenum PA, Hedman K, Naessens A. Am J Obstet Gynecol; 1999 Feb 15; 180(2 Pt 1):410-5. PubMed ID: 9988811 [Abstract] [Full Text] [Related] Page: [Next] [New Search]